×
Close
Sign Up
Login
Home
People
Photos
Videos
Topics
Bookmarks
Who viewed me
Events
Services
MDLA Events Platform
MDLA Events
MDLA Events Services & Pricing
Media Services & Pricing
User Tools
FAQ
Questions
User Notes
Feedback
Advertise with Us
Languages
English
中文
French
Português
Español
Arabic
Russian
About Us
Contact Us
Mary Grace N. Tamio
on April 03 2021 at 08:01 PM
Edited
public
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer
#fistula
#organperforation
#lenvatinib
#thyroidcancer
#karger
For more information | ⬇️
https://social.cn1699.cn/livenewss/news/56891/Prevalence-and-Risk-Factors-of-Developing-Fistula-or-Organ-Perforation-in-Patients-Treated-with-Lenvatinib-for-Radioiodine-Refractory-Thyroid-Cancer
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
gif
Please login or register
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?